In patients undergoing transfemoral coronary angiography and percutaneous coronary intervention (PCI), use of a vascular closure device results in reduced rates of complications compared with manual ...
New data presented Saturday at TCT 2014 show that, in patients undergoing transfemoral coronary angiography, vascular closure devices match manual compression in terms of vascular access site ...
Results from the largest randomized trial available comparing different closure device strategies following transcatheter aortic valve replacement (TAVR) found that a plug-based vascular closure ...
In an analysis of the ISAR-CLOSURE trial, use of vascular closure devices was as safe and effective as manual compression for artery closure in women undergoing transfemoral angiography. Researchers ...
Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of acute kidney injury (AKI) ...
June 2, 2010 (Kansas City, Missouri) — A treatment strategy that involves the use of a vascular closure device and bivalirudin (Angiomax, the Medicines Company) reduces the risk of periprocedural ...
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced that it received premarket approval (PMA) ...
The global vascular closure devices market is expected to reach USD 984.6 million by 2022 from USD 704.8 million in 2017, at a CAGR of 6.9%. The market is segmented on the basis of type, access, ...
The process of assuring the safety of medical devices is constrained by reliance on voluntary reporting of adverse events. We evaluated a strategy of prospective, active surveillance of a national ...
DUBLIN--(BUSINESS WIRE)--The "Peripheral Vascular Devices Market Report Suite | United States | 2020-2026 | MedSuite" report has been added to ResearchAndMarkets.com's offering. One of the greatest ...
ORLANDO – November 5, 2021 – Results from the largest randomized trial available comparing different closure device strategies following transcatheter aortic valve replacement (TAVR) found that a plug ...